dc.contributor.author | Samani, KG | |
dc.contributor.author | Noori, M | |
dc.contributor.author | Nobar, MR | |
dc.contributor.author | Chaleshtori, MH | |
dc.contributor.author | Farrokhi, E | |
dc.contributor.author | Amin, MD | |
dc.date.accessioned | 2018-08-26T08:57:20Z | |
dc.date.available | 2018-08-26T08:57:20Z | |
dc.date.issued | 2009 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54561 | |
dc.description.abstract | Background: Cholesteryl ester transfer protein (CETP) plays a main role in high-density lipoprotein metabolism. CETP gene possesses several single nucleotide polymorphisms which have been associated with plasma high-density lipoprotein cholesterol (HDL-C) concentrations. The aim of this study was to determine the association of CETP -629C/A and I405V polymorphisms with coronary artery disease (CAD) in Iranian population. Methods: The presence of two CETP gene polymorphisms -629C/A and I405V were studied in 187 unrelated CAD cases and 136 controls. All the samples were clinically examined and lipid profile was estimated. Genotyping was performed using polymerase chain reaction/restriction fragment length polymorphism method. Results: The frequency of -629C/A and I405V allelic variants were found to be 0.732 and 0.366 in cases and 0.658 and 0.348 in controls, respectively. The frequency of A allele of -629C/A polymorphism in cases was significantly higher than that of controls. HDL-C in AA genotype was higher than CA and CC genotypes in controls. No significant effect of II, IV and VV genotypes was found in lipid profiles. Conclusion: No significant association was found between CETP I405V polymorphism and increased risk of CAD in Azeri population studied. AA genotype of -629C/A increased HDL but the risk of CAD in this genotype might be higher than CC genotype. | |
dc.language.iso | English | |
dc.relation.ispartof | Iranian Biomedical Journal | |
dc.subject | cholesterol ester transfer protein | |
dc.subject | lipid | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | controlled study | |
dc.subject | coronary artery disease | |
dc.subject | disease association | |
dc.subject | DNA polymorphism | |
dc.subject | female | |
dc.subject | gene frequency | |
dc.subject | genetic risk | |
dc.subject | genotype | |
dc.subject | human | |
dc.subject | lipid blood level | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | polymerase chain reaction | |
dc.subject | restriction fragment length polymorphism | |
dc.subject | Amino Acid Substitution | |
dc.subject | Anthropometry | |
dc.subject | Cholesterol Ester Transfer Proteins | |
dc.subject | Coronary Artery Disease | |
dc.subject | Gene Frequency | |
dc.subject | Genotype | |
dc.subject | Humans | |
dc.subject | Isoleucine | |
dc.subject | Middle Aged | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | Valine | |
dc.title | I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease | |
dc.type | Article | |
dc.citation.volume | 13 | |
dc.citation.issue | 2 | |
dc.citation.spage | 103 | |
dc.citation.epage | 108 | |
dc.citation.index | Scopus | |